ArticleBMC bioinformatics2021
SMILE: systems metabolomics using interpretable learning and evolution.
Article in BMC bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Advances in postmortem interval estimation: A systematic review of machine learning and metabolomics across various tissue types.Forensic science, medicine, and pathology · 2025Pooled it
- Article
- A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit.The Journal of antimicrobial chemotherapy · 2026Review
- Elucidating the metabolic landscape of Bacillus velezensis WY-65 in basic and cocktail nutrient media: a biocontrol approach against peanut web blotch.Journal of biological engineering · 2026Article
- Metabolomic profiling of Bacillus amyloliquefaciens MU-10 and its antagonistic effects on Cercospora arachidicola.BMC microbiology · 2026Article
- Multivariate analyses and machine learning link sex and age with antibody responses to SARS-CoV-2 and vaccination.iScience · 2024Article
- Investigating the Potential of Essential Oils fromPlants (Basel, Switzerland) · 2024Article
- Explainable AI for clinical and remote health applications: a survey on tabular and time series data.Artificial intelligence review · 2023Article
- Opening the black box: interpretable machine learning for predictor finding of metabolic syndrome.BMC endocrine disorders · 2022Article
- Interpretable machine learning methods for predictions in systems biology from omics data.Frontiers in molecular biosciences · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDirect link between metabolism and cell and organism phenotype in health and disease makes metabolomics, a high throughput study of small molecular metabolites, an essential methodology for understanding and diagnosing disease development and progression. Machine learning methods have seen increasing adoptions in metabolomics thanks to their powerful prediction abilities. However, the "black-box" nature of many machine learning models remains a major challenge for wide acceptance and utility as it makes the interpretation of decision process difficult. This challenge is particularly predominant in biomedical research where understanding of the underlying decision making mechanism is essential for insuring safety and gaining new knowledge.
resultsIn this article, we proposed a novel computational framework, Systems Metabolomics using Interpretable Learning and Evolution (SMILE), for supervised metabolomics data analysis. Our methodology uses an evolutionary algorithm to learn interpretable predictive models and to identify the most influential metabolites and their interactions in association with disease. Moreover, we have developed a web application with a graphical user interface that can be used for easy analysis, interpretation and visualization of the results. Performance of the method and utilization of the web interface is shown using metabolomics data for Alzheimer's disease.
conclusionsSMILE was able to identify several influential metabolites on AD and to provide interpretable predictive models that can be further used for a better understanding of the metabolic background of AD. SMILE addresses the emerging issue of interpretability and explainability in machine learning, and contributes to more transparent and powerful applications of machine learning in bioinformatics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.